SI20802A - Modulacija imunskega odgovora z ribavirinom - Google Patents

Modulacija imunskega odgovora z ribavirinom Download PDF

Info

Publication number
SI20802A
SI20802A SI9920099A SI9920099A SI20802A SI 20802 A SI20802 A SI 20802A SI 9920099 A SI9920099 A SI 9920099A SI 9920099 A SI9920099 A SI 9920099A SI 20802 A SI20802 A SI 20802A
Authority
SI
Slovenia
Prior art keywords
nucleoside
challenge
ribavirin
immune system
cells
Prior art date
Application number
SI9920099A
Other languages
English (en)
Slovenian (sl)
Inventor
Robert Tam
Original Assignee
Icn Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals, Inc. filed Critical Icn Pharmaceuticals, Inc.
Publication of SI20802A publication Critical patent/SI20802A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SI9920099A 1999-01-29 1999-12-20 Modulacija imunskega odgovora z ribavirinom SI20802A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24136799A 1999-01-29 1999-01-29
PCT/US1999/030490 WO2000044388A1 (en) 1999-01-29 1999-12-20 Modulation of immune response by ribavirin

Publications (1)

Publication Number Publication Date
SI20802A true SI20802A (sl) 2002-08-31

Family

ID=22910442

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9920099A SI20802A (sl) 1999-01-29 1999-12-20 Modulacija imunskega odgovora z ribavirinom

Country Status (20)

Country Link
EP (1) EP1146883A4 (no)
JP (1) JP2002535371A (no)
KR (1) KR20020023939A (no)
CN (1) CN1334736A (no)
AU (1) AU2483300A (no)
BR (1) BR9917090A (no)
CA (1) CA2357735A1 (no)
CZ (1) CZ20012519A3 (no)
HK (1) HK1040937A1 (no)
HR (1) HRP20010496A2 (no)
HU (1) HUP0200027A2 (no)
IL (1) IL144130A0 (no)
MX (1) MXPA01007211A (no)
NO (1) NO20013529L (no)
PL (1) PL364699A1 (no)
RU (1) RU2211698C2 (no)
SI (1) SI20802A (no)
SK (1) SK10092001A3 (no)
WO (1) WO2000044388A1 (no)
ZA (1) ZA200105595B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311289B1 (en) 2000-08-17 2007-10-17 Tripep Ab Vaccines containing ribavirin
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
EP1993564A4 (en) * 2006-03-14 2010-05-26 Wholesome Biopharma Pty Ltd METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
EP0038629A1 (en) * 1980-04-17 1981-10-28 Beecham Group Plc Virazole derivatives, process for their preparation and use as antiviral agents
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
US5030623A (en) * 1986-03-27 1991-07-09 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
BR8607124A (pt) * 1986-03-27 1988-04-05 Harry Edward Gruber Um metodo de aumentar a excrecao de adenosina
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
PT879056E (pt) * 1996-01-23 2002-10-31 Ribapharm Inc Modulacao da expressao das citocinas th1/th2 atraves de ribavirina em linfocitos t activados
DE69721339T2 (de) * 1996-10-16 2004-01-22 Ribapharm, Inc., Costa Mesa Monozyklische l-nukleoside, analoga und ihre anwendungen

Also Published As

Publication number Publication date
AU2483300A (en) 2000-08-18
EP1146883A4 (en) 2004-11-24
NO20013529D0 (no) 2001-07-17
HUP0200027A2 (en) 2002-04-29
MXPA01007211A (es) 2002-05-06
KR20020023939A (ko) 2002-03-29
EP1146883A1 (en) 2001-10-24
CA2357735A1 (en) 2000-08-03
NO20013529L (no) 2001-09-12
HRP20010496A2 (en) 2003-08-31
JP2002535371A (ja) 2002-10-22
CZ20012519A3 (cs) 2002-05-15
RU2211698C2 (ru) 2003-09-10
HK1040937A1 (zh) 2002-06-28
IL144130A0 (en) 2002-05-23
BR9917090A (pt) 2001-10-16
WO2000044388A1 (en) 2000-08-03
PL364699A1 (en) 2004-12-13
CN1334736A (zh) 2002-02-06
SK10092001A3 (sk) 2002-02-05
ZA200105595B (en) 2002-10-07

Similar Documents

Publication Publication Date Title
US6815542B2 (en) Nucleoside compounds and uses thereof
JP2688113B2 (ja) 多発性硬化症の治療のための置換アデニン誘導体を含む薬学的組成物
SI21077A (sl) Analogi nukleozidov z biciklično bazo, modificirano s karboksamidinom
JP2004505889A (ja) ヌクレオシド化合物およびその使用
JPH0215523B2 (no)
US6423695B1 (en) Cytokine related treatments of disease
US4880918A (en) Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate
JPH06508846A (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤毒性の治療
RU95116361A (ru) Фармацевтический состав для профилактики и лечения раковых заболеваний, способ его получения, способ профилактики и лечения раковых заболеваний, способ изготовления лекарства для лечения рака, способ изготовления лекарства для профилактики рака
SI20802A (sl) Modulacija imunskega odgovora z ribavirinom
US20020187945A1 (en) Modulation of immune response by ribavirin
AU732120B2 (en) Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
SI9820003A (sl) Zdravljenje bolezni povezano s citokini
SI20976A (sl) Sestavki in postopki za L-nukleozide, L-nukleotide in njihove analoge
US6342485B1 (en) Synergistic compositions useful as anti-tumor agents
JPS63316722A (ja) インターフェロンの腫瘍成長抑制作用増強剤
KR20030040416A (ko) 간세포에 약물을 전달하는 방법 및 플라비비리대 감염을치료하는 방법
WO2013056510A1 (zh) 脱氧核苷与核苷组合在制备肿瘤药物中的应用
CN106928298A (zh) 环二核苷酸cGAMP衍生物的结构组成、制备方法及其在抗肿瘤中的应用
EP0290817A2 (en) A Use of oxetanocin for inhibiting HIV
CN104998262B (zh) Dpp4抑制剂在防治辐射诱导骨髓抑制药物中的应用
CN114010657A (zh) 卵巢癌细胞在制备治疗胰腺癌药物中的应用
CN117982658A (zh) Enpp1抑制剂和胞外核苷酸酶抑制剂在协同抑制肿瘤中的应用
NZ512879A (en) Modulation of immune response by Ribavirin
CN115968294A (zh) Nmn在降低免疫缺陷和免疫衰老中的应用

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20050830